News

RA-BEAM trial shows that baricitinib improves RA symptoms, slows joint damage
Results of the phase III RA-BEAM trial indicate that the JAK inhibitor baricitinib has superior efficacy over placebo and adalimumab when taken in...
Results of the phase III RA-BEAM trial indicate that the JAK inhibitor baricitinib has superior efficacy over placebo and adalimumab when taken in...
What percentage of periviable infants can survive without impairment?
ORLANDO – Some people with advanced kidney cancer continued to get clinical benefits even after stopping checkpoint inhibitor therapy.
The proposal sets off President Trump’s efforts to reform Obamacare.
There’s no one way to stop or taper medications for young patients with clinically inactive JIA.
Long-term success will come to practices that understand the implications of episode payments, specialty medical homes, and total cost of care.
Data show that malpractice claims have decreased twofold and insurance premiums are down, but experts say national reforms are still needed to...
Strong evidence exists that Western health professionals miss opportunities for hepatitis B virus testing and vaccination of Chinese migrant...
“I was at a crossroads in my career when I received funding from the AGA.”
SNOWMASS, COLO. – The use of coronary artery calcium screening in the subset of asymptomatic diabetes patients at higher clinical risk of CAD...